Back to the directory

Pardes Biosciences

We break viruses

Founded
2020
Status
Public
Stage
Early
Team size
2
Location
San Francisco, CA, USA; Remote
Category
Biotech & Drug Discovery
Sector
Drug Discovery and Delivery

About Pardes Biosciences

We make oral drugs to treat and prevent viral infections - like COVID-19.

BiotechTherapeutics

Clinical trials

2 registered trials with this company as lead sponsor, 2021 to 2022.

Phases
Phase 1 (1), Phase 2 (1)
Status
Completed (1), Terminated (1)
Conditions
Covid19, COVID-19

NCT05011812, NCT05543707

Source: ClinicalTrials.gov.

Securities filings

1 Form D filing on record, 2021.

Filed as Pardes Biosciences, Inc

CIK 0001842257

Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.

Company data compiled and maintained by Healthcare Discovery.